|
Telemedicine allows healthcare professionals to remotely monitor,
diagnose, and care for patients in their home and work environments.
Telemedicine leverages a combination of advanced remote monitoring
devices, telecommunication technology and innovative software and
hardware solutions to enable sophisticated medical care outside of
traditional medical institutions (i.e. hospitals and clinics).

Telemedicine is attracting extraordinary interest. The reason for
this is simple – telemedicine represents a "win-win-win"
solution for healthcare systems:
-
Win for health services: Telemedicine dramatically reduces the costs of
caring for the most expensive chronic disease patients
-
Win for caregivers: Telemedicine significantly improves the medical
outcome of many patient conditions
-
Win for patients and their families: Telemedicine greatly enhances
patient comfort, convenience, security, and peace-of-mind
It is little wonder therefore that telemedicine has been identified
by leading analysts as one of the fastest growing sectors of the
medical industry.
Telcomed technologies are developed in our own advanced research and
development laboratories, and manufactured under strict quality
standards.
The Telcomed platform provides advanced telemedicine capabilities. It
receives medical data using a variety of communication channels (telephone lines, Internet and Cellular), and
unifies the data into a user-friendly interface. The system
processes, analyses and stores medical monitoring data according to
a wide range of selectable criteria and offers a host of intuitive
display-options at the operator station.
The platform elements are designed to fit unobtrusively into a
patient’s life-style. They have been carefully designed to look and
feel like typical consumer products, and not like intimidating
medical devices.
The Telcomed platform is widely acknowledged as a breakthrough in
the industry. It provides better performance, better user
friendliness, higher flexibility, and lower cost than any solution
on the market.
Read
more...
|